Immunologic Insights on the Membrane Proximal External Region: A Major Human Immunodeficiency Virus Type-1 Vaccine Target

Immunologic Insights on the Membrane Proximal External Region: A Major Human Immunodeficiency Virus Type-1 Vaccine Target

Broadly neutralizing antibodies (bNAbs) targeting conserved regions within the human immunodeficiency virus type-1 (HIV-1) envelope glycoprotein (Env) can be generated by the human immune system and their elicitation by vaccination will be a key point to protect against the wide range of viral diver...

Full description

Bibliographic Details
Main Authors:	Luis M. Molinos-Albert, Bonaventura Clotet, Julià Blanco, Jorge Carrillo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-09-01
Series:	Frontiers in Immunology
Subjects:	human immunodeficiency virus type-1 broadly neutralizing antibodies membrane proximal external region B-cells polyreactivity membrane interaction
Online Access:	http://journal.frontiersin.org/article/10.3389/fimmu.2017.01154/full

Similar Items

Antibodies and Antibody Derivatives: New Partners in HIV Eradication Strategies
by: Jorge Carrillo, et al.
Published: (2018-10-01)

Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing Antibody
by: Young D. Kwon, et al.
Published: (2018-02-01)

A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies
by: Meredith E. Davis-Gardner, et al.
Published: (2020-01-01)

Circulating Plasmablasts from Chronically Human Immunodeficiency Virus-Infected Individuals Predominantly Produce Polyreactive/Autoreactive Antibodies
by: Hongyan Liao, et al.
Published: (2017-12-01)

Autoimmune B Cell Repertoire in a Mouse Model of Sjögren’s Syndrome
by: Manuel Sáez Moya, et al.
Published: (2021-04-01)

Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS
by: Martina S. Wesley, et al.
Published: (2021-08-01)

Feline Immunodeficiency Virus (FIV) Neutralization: A Review
by: Margaret J. Hosie, et al.
Published: (2011-10-01)

Fundamental differences between natural antibodies and polyreactive immunoglobulins
by: S. A. Bobrovnik, et al.
Published: (2015-10-01)

Elicitation of antibody responses against the HIV-1 gp41 Membrane Proximal External Region (MPER)
by: Cheng, Yuxing
Published: (2014)

Multiscale affinity maturation simulations to elicit broadly neutralizing antibodies against HIV
by: Chakraborty, A.K, et al.
Published: (2022)

Poly- and autoreactivity of HIV-1 bNAbs: implications for vaccine design
by: Joel Finney, et al.
Published: (2018-07-01)

Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity
by: Julie Prigent, et al.
Published: (2018-05-01)

Structural basis for germline antibody recognition of HIV-1 immunogens
by: Louise Scharf, et al.
Published: (2016-03-01)

Neutralizing Antibody-Based Prevention of Cell-Associated HIV-1 Infection
by: Matthew S Parsons, et al.
Published: (2018-06-01)

Biological and immunochemical properties of polyreactive immunoglobulins
by: S. A. Bobrovnik, et al.
Published: (2015-06-01)

Effect of trifluoroethanol on antibody reactivity against corresponding and nonrelated antigens
by: S. A. Bobrovnik, et al.
Published: (2018-07-01)

Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies
by: Haoqing Wang, et al.
Published: (2017-05-01)

Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
by: Matthew S. Parsons, et al.
Published: (2018-08-01)

Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for ‘Universal’ Influenza Vaccines
by: Maya Sangesland, et al.
Published: (2021-02-01)

Cross-reactive broadly neutralizing antibodies: timing is everything
by: Zelda eEuler, et al.
Published: (2012-07-01)

DNA Vaccine-Encoded Flagellin Can Be Used as an Adjuvant Scaffold to Augment HIV-1 gp41 Membrane Proximal External Region Immunogenicity
by: Lara Ajamian, et al.
Published: (2018-02-01)

Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies
by: Zhiqing Zhang, et al.
Published: (2016-11-01)

Broad Neutralization as a Byproduct of Antibody Maturation during HIV-1 Infection: a Personal Perspective
by: Feng Gao
Published: (2016-07-01)

Production of Autoreactive Heavy Chain-Only Antibodies in Systemic Lupus Erythematosus
by: Shu Xu, et al.
Published: (2020-05-01)

Passive Immunization against HIV/AIDS by Antibody Gene Transfer
by: Lili Yang, et al.
Published: (2014-01-01)

Eradication of Human Immunodeficiency Virus Type-1 (HIV-1)-Infected Cells
by: Nejat Düzgüneş, et al.
Published: (2019-06-01)

Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV
by: Allison B. Powell, et al.
Published: (2020-12-01)

The role of follicular helper CD4 T cells in the development of HIV-1 specific broadly neutralizing antibody responses
by: Eirini Moysi, et al.
Published: (2018-08-01)

Proteins Inside Cells and On the Surface of Membranes: Developing Three Dimensional In-Cell NMR and Structural Characterization of a Trimeric Membrane Proximal External Region Construct from HIV-1 gp41
by: Reardon, Patrick Neal
Published: (2011)

Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B′ Infected Plasma Donor with Broadly Neutralizing Activity
by: Yuanyuan Hu, et al.
Published: (2021-03-01)

Oxidation-Specific Epitopes (OSEs) Dominate the B Cell Response in Murine Polymicrobial Sepsis
by: Oliver Nicolai, et al.
Published: (2020-07-01)

Machine Learning to Quantify In Situ Humoral Selection in Human Lupus Tubulointerstitial Inflammation
by: Andrew J. Kinloch, et al.
Published: (2020-11-01)

Editorial: Membrane Trafficking in Immunology - How Membrane Transport and Exocytosis Defects Underlie Immunodeficiencies
by: Paul T. Manna, et al.
Published: (2021-09-01)

Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers
by: Veronique Demers-Mathieu, et al.
Published: (2021-02-01)

Interaction peculiarities of polyreactive immunoglobulins and various antigens
by: S. A. Bobrovnik, et al.
Published: (2014-02-01)

Broadly Neutralizing Bovine Antibodies: Highly Effective New Tools against Evasive Pathogens?
by: Matthew J. Burke, et al.
Published: (2020-04-01)

Immunologic Basis for Long HCDR3s in Broadly Neutralizing Antibodies against HIV-1
by: Lei eYu, et al.
Published: (2014-06-01)

An ultralong CDRH2 in HCV neutralizing antibody demonstrates structural plasticity of antibodies against E2 glycoprotein
by: Andrew I Flyak, et al.
Published: (2020-03-01)

Neutralizing Antibodies Targeting the Conserved Stem Region of Influenza Hemagglutinin
by: Sabari Nath Neerukonda, et al.
Published: (2020-07-01)

Phage display as a tool for identifying HIV-1 broadly neutralizing antibodies
by: A. N. Chikaev, et al.
Published: (2021-09-01)